LUPIN

Lupin launches Rivaroxaban Tablets in US, following the final approval from the US FDA for the Company’s Abbreviated New Drug Application

Lupin launches Rivaroxaban Tablets in US, following the final approval from the US FDA for the Company’s Abbreviated New Drug Application Alert: Rivaroxaban is used to reduce risk of major cardiovascular events in patients with coronary artery disease Alert: Rivaroxaban is used to reduce risk of major thrombotic vascular events in patients with peripheral artery disease